SJL-01

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameSJL-01

Drug Alias NameSJL-01

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLeishmaniasis, Visceral

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHoshi University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesHoshi University

Active IndicationsN/A

Inactive IndicationsLeishmaniasis, Visceral

ATC CodeN/A